Recruiting Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases NCT07283315 Conditions Autoimmune Diseases, CAR, Immune System Diseases, +1 more Locations Children's Hospital of Zhejiang University School of Medicine — Hangzhou, Zhejiang, China View Trial Details
Recruiting GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression NCT03198546 Conditions Adenocarcinoma, CAR, Carcinoma, +15 more Locations The First Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China The Second Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China View Trial Details
Recruiting CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol NCT05648019 Conditions B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more Locations Singapore General Hospital — Singapore KK Women's and Children's Hospital — Singapore View Trial Details
Recruiting CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia NCT05043571 Conditions CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +16 more Locations Allen Yeoh Eng Juh — Singapore View Trial Details
Recruiting ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. NCT05038696 Conditions CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +14 more Locations Allen Yeoh Eng Juh — Singapore View Trial Details
